NEOVACS |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1436 EUR | -2.97% |
|
-29.68% | -92.82% |
| 05-29 | Neovacs: mRNA approach validated in preclinical trial | CF |
| 05-27 | Neovacs: collaboration contract with INSERM team | CF |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.2550 | 0.5100 | 29.99 |
| Spread/Res. | -43.69% | -71.84% | -99.52% |
| Spread/Supp. | +15.43% | +166.42% | +121.60% |
| Support | 0.1244 | 0.0539 | 0.0648 |
- Stock Market
- Equities
- ALNEV Stock
- Charts NEOVACS
